Market Overview

UPDATE: Canaccord Genuity Upgrades Bed Bath & Beyond to Buy on Cost Plus Catalyst

Related BBBY
Not Just A Toy Story: Market Winners And Losers From The Toys 'R' Us Liquidation
Analyst: Toys R Us Closures Could Be Positive Catalyst For Bed Bath & Beyond

Canaccord Genuity raised its rating on Bed Bath & Beyond (NASDAQ: BBBY) from Hold to Buy and increased its price target from $71 to $75.

Canaccord Genuity noted, "BBBY shares have declined 15% since 6/20 when the company issued Q2 EPS guidance that fell short of expectations. … We view this as an opportunity for investors to buy a high-quality company just as the addition of Cost Plus becomes a potential growth lever. We believe Cost Plus' contribution to EPS will grow from $0.01 in F2012 to $0.32 by F2016. BBBY still has around $1B in cash following recent acquisitions which will support much-needed investments in technology and the return of capital to shareholders."

Bed Bath & Beyond closed at $62.78 on Friday.

Latest Ratings for BBBY

Jan 2018JP MorganDowngradesNeutralUnderweight
Dec 2017Moffett NathansonInitiates Coverage OnNeutral
Nov 2017KeyBancMaintainsUnderweight

View More Analyst Ratings for BBBY
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings


Related Articles (BBBY)

View Comments and Join the Discussion!